Equities

GRI Bio Inc

GRI:NAQ

GRI Bio Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.4408
  • Today's Change-0.019 / -4.17%
  • Shares traded89.75k
  • 1 Year change-99.69%
  • Beta-1.7063
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects GRI Bio Inc share price to rise to 12.00 in the next year from the last price of 0.4408.
High2,622.3%12.00
Med2,622.3%12.00
Low2,622.3%12.00

Earnings history & estimates in USD

Earnings forecasts are not available for GRI Bio Inc. On Nov 03, 2022, GRI Bio Inc reported 3rd quarter 2022 losses of -- per share.
Average growth rate+31.97%
GRI Bio Inc reported annual 2021 losses of -3,876.60 per share on Feb 14, 2022.
More ▼

Revenue history & estimates in USD

Revenue forecasts are not available for GRI Bio Inc.
Average growth rate0.00%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.